Unlocking the Secret of Pain Management with Juva Life (OTCQB: JUVAF)

<p>"What we identified is that the cannabinoids for inflammation controlling the primary cytokine pathways in the human body - cannabinoids have almost no therapeutic effects compared to JUVA  19 or JUVA 41." </p><p>"When we combined any other cannabinoid - THC, CBD - the combination of flavonoids and what we would know as the entourage effect with any of our JUVA 41 or JUVA 19, it down-regulated their potency and activity, full stop!"  ~Doug Chloupek, the CEO and Founder of Juva Life</p><p>Doug Chloupek, the CEO and Founder of Juva Life (OTCQB: JUVAF) - Juva Life is a cannabis cultivation and life sciences company aimed of unlocking the secret of pain management, and has navigated the complex financial regulatory system in order to make Juva a publicly traded company in the USA, Canada, and Germany, collectively raising $38 Million to-date.</p><p>Episode 965 The #TalkingHedge interviews Doug Chloupek, CEO & Founder at Juva Life...</p><p><a href="https://youtu.be/gy8MPyPXV0Q">https://youtu.be/gy8MPyPXV0Q</a></p><p> </p><p> </p>